Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses
暂无分享,去创建一个
[1] H. Sasano,et al. Significance of fat stains in serial sections from Epon-embedded tissue samples for electron microscopy in renal diseases , 2001, Clinical and Experimental Nephrology.
[2] I. Sakata,et al. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity. , 2001, Kidney international.
[3] W. März,et al. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy. , 2001, Journal of the American Society of Nephrology : JASN.
[4] T. Ohno,et al. A newborn infant with lipoprotein glomerulopathy associated with congenital nephrotic syndrome , 2001, Pediatrics international : official journal of the Japan Pediatric Society.
[5] S. Hadjadj,et al. Lack of relationship in long‐term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein ε, lipoprotein lipase and cholesteryl ester transfer protein , 2000 .
[6] M. Polenaković,et al. New Cases of Lipoprotein Glomerulopathy? , 2000, Nephron.
[7] D. Moczulski,et al. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies. , 2000, Diabetes.
[8] M. Taskinen,et al. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients , 2000, Diabetologia.
[9] Takashi Suzuki,et al. Virus-mediated Transduction of Apolipoprotein E (ApoE)-Sendai Develops Lipoprotein Glomerulopathy in ApoE-deficient Mice* , 2000, The Journal of Biological Chemistry.
[10] H. Parving,et al. Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] K. Maruyama,et al. A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy , 2000, Pediatric Nephrology.
[12] T. Saruta,et al. Association of a Novel 3-Amino Acid Deletion Mutation of Apolipoprotein E (Apo E Tokyo) with Lipoprotein Glomerulopathy , 1999, Nephron.
[13] J. Sasaki,et al. Lipoprotein Glomerulopathy: Renal Lipidosis Induced by Novel Apolipoprotein E Variants , 1999, Nephron.
[14] N. Yorioka,et al. Apolipoprotein E Polymorphism in IgA Nephropathy , 1999, Nephron.
[15] J. Sasaki,et al. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy. , 1999, Kidney international.
[16] T. Kita,et al. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. , 1999, Kidney international.
[17] J. Sasaki,et al. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features. , 1999, Kidney international. Supplement.
[18] N. Yorioka,et al. Apolipoprotein E polymorphism and renal disease. , 1999, Kidney international. Supplement.
[19] M. Nangaku,et al. Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney. , 1999, Journal of the American Society of Nephrology : JASN.
[20] Bozhang,et al. Possible Induction of Renal Dysfunction in Patients With Lecithin:Cholesterol Acyltransferase Deficiency by Oxidized Phosphatidylcholine in Glomeruli , 1999 .
[21] A. Djamali,et al. Lipoprotein glomerulopathy: a new cause of nephrotic syndrome after renal transplantation. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] D. Tarng,et al. Association of Apolipoprotein E Polymorphism with Lipoprotein Glomerulopathy , 1998, Nephron.
[23] J. Todd,et al. Association of Apolipoprotein ε2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM , 1998, Diabetes.
[24] M. Bewick,et al. Recurrence of lipoprotein glomerulopathy after renal transplantation. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[25] S. Oikawa,et al. Lipoprotein glomerulopathy and its pathogenesis. , 1997, Contributions to nephrology.
[26] J. Sasaki,et al. Apolipoprotein E Sendai (arginine 145-->proline): a new variant associated with lipoprotein glomerulopathy. , 1997, Journal of the American Society of Nephrology : JASN.
[27] R. Lifton,et al. Lipoprotein glomerulopathy: a new role for apolipoprotein E? , 1997, Journal of the American Society of Nephrology : JASN.
[28] K. Maruyama,et al. Lipoprotein glomerulopathy: a pediatric case report , 1997, Pediatric nephrology (Berlin, West).
[29] T. Saito. Abnormal lipid metabolism and renal disorders. , 1997, The Tohoku journal of experimental medicine.
[30] J. Niall,et al. Glomerular lipid deposition and proteinuria in a patient with familial dysbetalipoproteinaemia , 1996, Journal of internal medicine.
[31] A. Krolewski,et al. Apolipoprotein E genotypes and risk of diabetic nephropathy. , 1996, Journal of the American Society of Nephrology : JASN.
[32] T. Orchard,et al. Atypical hyperlipidemia and nephropathy associated with apolipoprotein E homozygosity. , 1995, Journal of the American Society of Nephrology : JASN.
[33] T. Kita,et al. Lipoprotein glomerulopathy with a new apolipoprotein E phenotype. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] A. Meyrier,et al. Lipoprotein glomerulopathy: first case in a white European. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] S. Oikawa,et al. Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury , 1995 .
[36] M. Eto,et al. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. , 1995, Clinical genetics.
[37] A. Kumar,et al. Lipoprotein glomerulopathy: first report in a Chinese male. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] M. Haneda,et al. A case of lipoprotein glomerulopathy successfully treated with probucol. , 1994, Nephron.
[39] S. Oikawa,et al. Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature. , 1993, American journal of nephrology.
[40] S. Oikawa,et al. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[41] N. Kaneko,et al. A Case of Lipoprotein Glomerulopathy: Light and Electron Microscopic Observations of the Glomerulus , 1990, Acta pathologica japonica.
[42] M. Shichiri,et al. Effect of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus , 1990 .
[43] T. Sato,et al. Apolipoprotein-E2 and hyperlipoproteinemia in noninsulin-dependent diabetes mellitus. , 1989, The Journal of clinical endocrinology and metabolism.
[44] S. Matsuo,et al. A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis. , 1989, Nephron.
[45] T. Tomita,et al. [A case of nephrotic syndrome with a peculiar glomerular lesion]. , 1989, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.
[46] S. Oikawa,et al. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[47] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[48] T. Faraggiana,et al. Renal lipidoses: a review. , 1987, Human pathology.
[49] H. Holloway,et al. A comparison of standard lipid staining techniques used in electron microscopic studies of mammalian tissues. , 1984, Stain technology.
[50] R. Glassock,et al. Renal disease : classification and atlas , 1987 .
[51] E. Gjone. Familial lecithin:cholesterol acyltransferase deficiency - a new metabolic disease with renal involvement. , 1981, Advances in nephrology from the Necker Hospital.
[52] G. Hutchins,et al. Type 3 hyperlipoproteinemia with mesangial foam cells in renal glomeruli. , 1974, Archives of pathology.
[53] E. Korn,et al. 3. Modification of oleic acid during fixation of Amoebae by osmium tetroxide. , 1966, Biochimica et biophysica acta.